Skip to main content
Log in

The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats

  • Original Articles
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Summary

The interaction of µ-opioid receptors and G proteins after chronic morphine treatment was investigated in rats. Male Sprague-Dawley rats (200–260 g) were rendered tolerant to morphine by i.p. injections of increasing doses of morphine twice daily for 4 or 6 days. During this period, there was a time-dependent increase in the AD50 values for morphine to inhibit the tail-flick response. In addition, in vitro µ-opioid receptor binding to midbrain P2 membranes from these animals revealed that the ability of 10 μmol/l Gpp(NH)p (guanyl-5′-yl imidodiphosphate) to decrease [3H]DAMGO (TyrD-Ala-Gly-McPhe-Gly-ol) binding affinity, i.e., the ratio K d(+Gpp(NH)p)/K d(−Gpp(NH)p), decreased significantly from the control value of 3.68±0.40 to 2.37±0.35 after 6 days of morphine treatment (P<0.05).

The ability of DAMGO to stimulate low K m GTPase activity was also investigated. The EC50 significantly increased from 2.7± 1.1 × 10−8 mol/l in the control group to 10.8±1.5 × 10−8 mol/l after 4 days of morphine treatment and was further increased to 13.5±2.1 × 10−8 mol/l after 6 days of morphine treatment. The maximal stimulation by DAMGO decreased significantly from 18.0±1.7% to 12.8± 1.6% after 6 days of morphine treatment.

These results indicate that the interaction between µ-opioid receptors and G proteins had been altered after chronic morphine treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Barchfeld CC, Medzihradsky F (1984) Receptor-mediated stimulation of brain GTPase by opiates in normal and dependent rats. Biochem Biophys Res Commun 121:641–648

    Google Scholar 

  • Benovic JL, Pike LJ, Cerione RA, Staniszewski C, Yoshimasa T, Codina J, Caron MG, Lefkowitz RJ (1985) Phosphorylation of the mammalian β-adrenergic receptor by cyclic AMP-dependent protein kinase. J Biol Chem 260:7094–7101

    Google Scholar 

  • Benovic JL, Kuhn H, Weyand I, Codina J, Caron MT, Lefkowitz RJ (1987) Functional desensitization of the isolated β-adrenergic receptor by the β-adrenergic receptor kinase: potential role of an analog of the retinal protein arrestin (48-kDa protein). Proc Natl Acad Sci USA 84:8879–8882

    Google Scholar 

  • Blume AJ (1978) Interaction of ligands with the opiate receptors of brain membranes: regulation by ions and nucleotides. Proc Natl Acad Sci USA 75:1713–1717

    Google Scholar 

  • Burns DL, Hewlett EL, Moss J, Vaughan M (1983) Pertussis toxin inhibits enkephalin stimulation of GTPase of NG108–15 cells. J Biol Chem 258:1435–1438

    Google Scholar 

  • Cassel D, Selinger Z (1976) Catecholamine-stimulated GTPase activity in turkey erythrocyte membranes. Biochim Biophys Acta 452:538–551

    Google Scholar 

  • Chang K-J, Hazum E, Killian A, Cuatrecasas P (1981) Interactions of ligands with morphine and enkephalin receptors are differentially affected by guanine nucleotide. Mol Pharmacol 20:1–7

    Google Scholar 

  • Childers SR, Snyder SH (1980) Differential regulation by guanine nucleotides of opiate agonist and antagonist receptor interactions. J Neurochem 34:583–593

    Google Scholar 

  • D'Amour FE, Smith DL (1941) A method for determining loss of pain sensation. J Pharmacol Exp Ther 72:74–79

    Google Scholar 

  • Danks JA, Tortella FC, Bykov V, Jacobson AE, Rice KC, Holaday JW, Rothman RB (1988) Chronic administration of morphine and naltrexone up-regulate [3H][d-Ala2, d-Leu5]enkephalin binding sites by different mechanisms. Neuropharmacol 27:965–974

    Google Scholar 

  • Dixon WJ (1965) The up and down method for small samples. Am Stat Assoc J:967–978

  • Frances B, Moisand C, Meunier J-C (1985) Na+ ions and Gpp(NH)p selectively inhibit agonist interactions at µ-and κ-opioid receptor sites in rabbit and guinea-pig cerebellum membranes. Eur J Pharmacol 117:223–232

    Google Scholar 

  • Hitzemann RJ, Hitzemann BA, Loh HH (1974) Binding of [3H] naloxone in the mouse brain: Effect of ions and tolerance development. Life Sci 14:2393–2404

    Google Scholar 

  • Holaday JW, Hitzemann RJ, Curell J, Tortella FC, Belenky GL (1982) Repeated electroconvulsive shock or chronic morphine treatment increase the number of [3H]-d-Ala2, d-Leu5-enkephalin in binding sites in rat brain membranes. Life Sci 31:2359–2362

    Google Scholar 

  • Hollt V, Dum J, Blasig J, Schubert P, Herz A (1975). Comparison of in vivo and in vitro parameters of opiate receptor binding in naive and tolerant/dependent rats. Life Sci 16:1823–1828

    Google Scholar 

  • Klee WA, Streaty RA (1974) Narcotic receptor sites in morphine-dependent rats. Nature 248:61–63

    Google Scholar 

  • Koski G, Klee WA (1981) Opiates inhibit adenylate cyclase by stimulating GTP hydrolysis. Proc Natl Acad Sci USA 78:4185–4189

    Google Scholar 

  • Law PY, Hom DS, Loh HH (1982) Loss of opiate receptor activity in Neuroblastoma x Glioma NG108–15 hybrid cells after chronic opiate treatment: a multiple step process. Mol Pharmacol 22:1–4

    Google Scholar 

  • Law PY, Hom DS, Loh HH (1983) Opiate receptor down-regulation and desensitization in Neuroblastoma x Glioma NG108–15 hybrid cells are two separate cellular adaptation processes. Mol Pharmacol 24:413–424

    Google Scholar 

  • Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with Folin phenol reagent. J Biol Chem 193:265–275

    CAS  PubMed  Google Scholar 

  • McPherson GA (1983) A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed 17:107–114

    Google Scholar 

  • Munson PJ, Rodbard D (1980) LIGAND: A versatile computerized approach for characterization of ligand binding systems. Anal Biochem 107:220–239

    Google Scholar 

  • Parenti M, Gazzotti G, Tirone F, Groppetti A (1983) Opiate tolerance and dependence is associated with a decreased activity of GTPase in rat striatal membranes. Life Sci 33, Sup I:345–348

    Google Scholar 

  • Pert CB, Snyder SH (1976) Opiate receptor binding enhancement by opiate administration in vivo. Biochem Pharmacol 25:847–853

    Google Scholar 

  • Puttfarcken PS, Werling LL, Cox BM (1988) Effects of chronic morphine exposure on opioid inhibition of adenylyl cyclase in 7315c cell membranes: A useful model for the study of tolerance at µ opioid receptor. Mol Pharmacol 33:520–527

    Google Scholar 

  • Rogers NF, el-Fakahany E (1986) Morphine-induced opioid receptor down-regulation detected in intact adult rat brain cells. Eur J Pharmacol 124:221–230

    Google Scholar 

  • Rothman RB, Danks JA, Jacobson AE, Burke TR, Burke TR Jr, Rice KC, Tortella FC, Holaday JW (1986) Morphine tolerance increases mu-noncompetitive delta binding sites. Eur J Pharmacol 124: 113–119

    Google Scholar 

  • Rothman RB, Bykov V, Long JB, Brady LS, Jacobson AE, Rice KC, Holaday JW (1989) Chronic administration of morphine and naltrexone up-regulate mu-opioid binding sites labeled by [3H](d-Ala2, McPhe4, Gly-ol5)enkephalin: further evidence for two mu-binding sites. Eur J Pharmacol 160:71–82

    Google Scholar 

  • Simon EJ, Hiller JB (1978) In vitro studies on opiate receptors and their ligands. Fed Proc 37:141–146

    Google Scholar 

  • Sumner BE, Coombes JE, Pumford KM, Russell JA (1990) Opioid receptor subtypes in the supraoptic nucleus and posterior pituitary gland of morphine-tolerant rats. Neuroscience 37:635–645

    Google Scholar 

  • Tao P-L, Law PY, Loh HH (1987) Decrease in σ- and µ-opioid receptor binding capacity in rat brain after chronic etorphine treatment. J Pharmacol Exp Ther 240:809–816

    Google Scholar 

  • Tao P-L, Chang L-R, Law PY, Loh HH (1988) Decrease in σ-opioid receptor density in rat brain after chronic d-Ala2, d-Leu5-enkephalin treatment. Brain Res 462:313–320

    Google Scholar 

  • Tao P-L, Lee HY, Chang L-R, Loh HH (1990) Decrease in mu-opioid receptor binding capacity in rat brain after chronic PLO17 treatment. Brain Res 526:270–275

    Google Scholar 

  • Tao P-L, Tsai C-L, Chang L-R, Loh HH (1991) Chronic effect of (d-Pen2, d-Pen5)enkephalin on rat brain opioid receptors. Eur J Pharmacol 201:209–214

    Google Scholar 

  • Tempel A, Habas JE, Paredes W, Barr GA (1988) Morphine-induced downregulation of µ-opioid receptors in neonatal rat brain. Brain Res 469:129–133

    Google Scholar 

  • Vachon L, Costa T, Herz A (1985) Desensitization of opioid-stimulated GTPase in neuroblastoma x glioma hybrid cells. Biochem Biophys Res Commun 128:1342–1349

    Google Scholar 

  • Vachon L, Costa T, Herz A (1987) GTPase and adenylate cyclase desensitize at different rates in NG108–15 cells. Mol Pharmacol 31:159–168

    Google Scholar 

  • Werling LL, McMahon PN, Cox BM (1989) Selective changes in mu opioid receptor properties induced by chronic morphine exposure. Proc Natl Acad Sci USA 86:6393–6397

    Google Scholar 

  • Wilden U, Hall SW, Kuhn H (1986) Phosphodiesterase activation by photoexcited rhodopsin is quenched when rhodopsin is phosphorylated and binds the intrinsic 48-kDa protein of rod outer segments. Proc Natl Acad Sci USA 83:1174–1178

    Google Scholar 

  • Williams J, North RA (1983) Tolerance to opiates in locus coerulcus actions? Abstr Int Narc Res Conf p 49

  • Wong C-S, Su Y-F, Watkins WD, Chang K-J (1992) Continuous intrathecal opioid treatment abolishes the regulatory effects of magnesium and guanine nucleotides on mu opioid receptor binding in rat spinal membranes. J Pharmacol Exp Ther 262:317–326

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Correspondence to: P.-L. Tao at the above address

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tao, PL., Lee, CR., Law, PY. et al. The interaction of the mu-opioid receptor and G protein is altered after chronic morphine treatment in rats. Naunyn-Schmiedeberg's Arch Pharmacol 348, 504–508 (1993). https://doi.org/10.1007/BF00173210

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00173210

Key words

Navigation